Royal Bank of Canada
EW icon

Royal Bank of Canada’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$253M Buy
3,236,847
+1,265,508
+64% +$99M 0.05% 307
2025
Q1
$143M Sell
1,971,339
-316,342
-14% -$22.9M 0.03% 407
2024
Q4
$169M Buy
2,287,681
+315,968
+16% +$23.4M 0.03% 377
2024
Q3
$130M Sell
1,971,713
-491,970
-20% -$32.5M 0.03% 443
2024
Q2
$228M Sell
2,463,683
-257,649
-9% -$23.8M 0.05% 291
2024
Q1
$260M Buy
2,721,332
+59,249
+2% +$5.66M 0.06% 271
2023
Q4
$203M Sell
2,662,083
-1,334,940
-33% -$102M 0.05% 310
2023
Q3
$277M Sell
3,997,023
-698,748
-15% -$48.4M 0.08% 229
2023
Q2
$443M Buy
4,695,771
+226,787
+5% +$21.4M 0.12% 153
2023
Q1
$370M Sell
4,468,984
-348,205
-7% -$28.8M 0.1% 164
2022
Q4
$359M Sell
4,817,189
-37,343
-0.8% -$2.79M 0.1% 171
2022
Q3
$401M Sell
4,854,532
-434,004
-8% -$35.9M 0.13% 146
2022
Q2
$503M Sell
5,288,536
-833,153
-14% -$79.2M 0.15% 129
2022
Q1
$721M Sell
6,121,689
-379,528
-6% -$44.7M 0.18% 108
2021
Q4
$842M Sell
6,501,217
-13,588
-0.2% -$1.76M 0.19% 101
2021
Q3
$738M Sell
6,514,805
-8,160
-0.1% -$924K 0.19% 101
2021
Q2
$676M Buy
6,522,965
+445,786
+7% +$46.2M 0.18% 110
2021
Q1
$508M Sell
6,077,179
-697
-0% -$58.3K 0.15% 121
2020
Q4
$554M Buy
6,077,876
+43,762
+0.7% +$3.99M 0.16% 117
2020
Q3
$482M Buy
6,034,114
+825,011
+16% +$65.9M 0.17% 116
2020
Q2
$360M Buy
5,209,103
+3,548,301
+214% +$245M 0.14% 131
2020
Q1
$313M Buy
1,660,802
+180,644
+12% +$34.1M 0.15% 120
2019
Q4
$345M Sell
1,480,158
-144,652
-9% -$33.7M 0.12% 134
2019
Q3
$357M Sell
1,624,810
-26,030
-2% -$5.72M 0.14% 127
2019
Q2
$305M Buy
1,650,840
+110,497
+7% +$20.4M 0.12% 139
2019
Q1
$295M Buy
1,540,343
+79,390
+5% +$15.2M 0.13% 144
2018
Q4
$224M Sell
1,460,953
-84,276
-5% -$12.9M 0.11% 145
2018
Q3
$269M Buy
1,545,229
+43,373
+3% +$7.54M 0.11% 138
2018
Q2
$219M Sell
1,501,856
-48,521
-3% -$7.06M 0.1% 161
2018
Q1
$216M Buy
1,550,377
+129,036
+9% +$18M 0.1% 160
2017
Q4
$160M Buy
1,421,341
+98,277
+7% +$11.1M 0.07% 207
2017
Q3
$145M Buy
1,323,064
+3,216
+0.2% +$352K 0.07% 215
2017
Q2
$156M Buy
1,319,848
+8,946
+0.7% +$1.06M 0.08% 185
2017
Q1
$123M Buy
1,310,902
+142,249
+12% +$13.4M 0.07% 217
2016
Q4
$110M Buy
1,168,653
+21,336
+2% +$2M 0.06% 240
2016
Q3
$138M Buy
1,147,317
+558
+0% +$67.3K 0.08% 189
2016
Q2
$114M Sell
1,146,759
-32,603
-3% -$3.25M 0.07% 209
2016
Q1
$104M Buy
1,179,362
+51,619
+5% +$4.55M 0.06% 212
2015
Q4
$89.1M Buy
1,127,743
+911,409
+421% +$72M 0.06% 240
2015
Q3
$30.8M Buy
216,334
+69,800
+48% +$9.92M 0.02% 473
2015
Q2
$20.9M Buy
146,534
+7,068
+5% +$1.01M 0.01% 721
2015
Q1
$19.9M Sell
139,466
-19,884
-12% -$2.83M 0.01% 728
2014
Q4
$20.3M Buy
159,350
+46,695
+41% +$5.95M 0.01% 721
2014
Q3
$11.5M Buy
112,655
+40,877
+57% +$4.18M 0.01% 949
2014
Q2
$6.16M Sell
71,778
-3,185
-4% -$273K ﹤0.01% 1266
2014
Q1
$5.56M Sell
74,963
-25,368
-25% -$1.88M ﹤0.01% 1259
2013
Q4
$6.6M Buy
100,331
+7,514
+8% +$494K ﹤0.01% 1175
2013
Q3
$6.46M Sell
92,817
-13,608
-13% -$948K 0.01% 1146
2013
Q2
$7.15M Buy
+106,425
New +$7.15M 0.01% 988